Parkinson's disease and narcolepsy-like symptoms

Sleep Medicine

Volumn 16, Issue 4, 2015, Pages 540-544

  Ylikoski, Ari ^a,b   Martikainen, Kirsti ^c   Sarkanen, Tomi ^a,d   Partinen, Markku ^a,e  

^a Vitalmed Research Center   (Finland)

^b Laakso Acute Care Hospital   (Finland)

^c The Finnish Parkinson Association and Foundation   (Finland)

^d Central Finland Central Hospital   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cataplexy; Hallucination; Narcolepsy; Parkinson; REM behavior disorder

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BASIC NORDIC SLEEP QUESTIONNAIRE; CATAPLEXY; COHORT ANALYSIS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; EXCESSIVE DREAMING; FATIGUE; FEMALE; HALLUCINATION; HUMAN; HYPNAGOGIC HALLUCINATION; HYPNOPOMPIC HALLUCINATION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP DISORDER ASSESSMENT; STRUCTURED QUESTIONNAIRE; ULLANLINNA NARCOLEPSY SCALE; COMPLICATION; HALLUCINATIONS; MIDDLE AGED; QUESTIONNAIRE; REM SLEEP BEHAVIOR DISORDER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; SURVEYS AND QUESTIONNAIRES;

EID: 84926520726     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.12.010     Document Type: Article

References (37)

1. American Academy of Sleep Medicine. International classification of sleep disorders 2014, American Academy of Sleep Medicine, Darien, IL. 3rd ed.
2. Partinen M., et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014, 13(6):600-613.
3. Mignot E., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002, 59(10):1553-1562.
4. Andlauer O., et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012, 35(9):1247-1255.
5. Nightingale S., et al. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med 2005, 6(3):253-258. 1389-9457 (Print).
6. Baumann C., et al. Parkinsonism with excessive daytime sleepiness-a narcolepsy-like disorder?. J Neurol 2005, 252(2):139-145.
7. Crutch S.J., et al. Posterior cortical atrophy. Lancet Neurol 2012, 11(2):170-178.
8. Monaca C., et al. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med 2006, 7(5):448-453.
9. Arnulf I., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002, 58(7):1019-1024.
10. Arnulf I., et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000, 55(2):281-288.
11. Hobson D.E., et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002, 23-30:455-463. 287(4).
12. Romenets S., et al. Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord 2012, 18(1):54-58.
13. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007, 130(Pt 6):1586-1595.
14. Fronczek R., et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007, 130(Pt 6):1577-1585.
15. Partinen M., Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints. J Sleep Res 1995, 4(Suppl. 1):150-155.
16. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993, 103(1):30-36.
17. Hublin C.F.A.U.K., et al. The Ullanlinna Narcolepsy Scale: validation of a measure of symptoms in the narcoleptic syndrome. J Sleep Res 1994, 3(1):52-59.
18. Stiasny-Kolster K., et al. The REM sleep behavior disorder screening questionnaire - a new diagnostic instrument. Mov Disord 2007, 22(16):2386-2393.
19. Nomura T., et al. Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients. Sleep Med 2011, 12(7):711-713.
20. Allen R.P., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4(2):101-119.
21. Hublin C., et al. Epidemiology of narcolepsy. Sleep 1994, 17(8 Suppl.):S7-12.
22. Tafti M., et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014, 37(1):19-25.
23. Christine C.W., Marks W.J., Ostrem J.L. Development of Parkinson's disease in patients with Narcolepsy. J Neural Transm 2012, 119(6):697-699.
24. Wienecke M., et al. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?. J Sleep Res 2012, 21(6):710-717.
25. Mignot E., et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997, 20(11):1012-1020.
26. Nevsimalova S., et al. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol 2013, 260(3):767-775.
27. Holloway R.G., et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 2004, 61(7):1044-1053.
28. Drouot X., et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003, 61(4):540-543.
29. Goetz C., et al. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology 2010, 75:1773-1779.
30. Forsaa E., et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010, 67(8):996-1001.
31. Leu-Semenescu S., et al. Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson's disease. Sleep Med 2011, 12(5):497-504.
32. Factor S.A., et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003, 60(11):1756-1761.
33. Harding A.J., et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 2002, 125(Pt 11):2431-2445.
34. Moller J.C., et al. Continuous sleep EEG monitoring in PD patients with and without sleep attacks. Parkinsonism Relat Disord 2009, 15(3):238-241.
35. Overeem S., et al. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med 2011, 12(1):12-18.
36. Billiard M., et al. Excessive daytime somnolence in young men: prevalence and contributing factors. Sleep 1987, 10(4):297-305.
37. Partinen M. Sleeping habits and sleep disorders on finnish men before, during and after military service. Ann Med Milit Fenn 1982, 57(Suppl. 1):1-96.